Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the exchanges that the trading window for dealing in the company's shares has been closed, in line with SEBI's Prohibition of Insider Trading (PIT) Regulations. The window closure typically happens ahead of a board meeting to consider financial results or other price-sensitive matters, during which unpublished information is in the possession of insiders. Designated persons including directors, employees, and their immediate relatives will not be allowed to trade in the company's shares until the window reopens, usually 48 hours after the price-sensitive information is made public. The exact reopening date and the specific reason (such as the upcoming results or corporate action) are not detailed in this brief announcement.
This is a routine compliance announcement and does not by itself signal any positive or negative development. However, it does indicate that the company is likely preparing to share price-sensitive information in the near term, which investors should watch for.